back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-15 16:52 Tx date 2024-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,658
+527 vol $8.84 each |
364,288 | |
| Filed 2024-03-28 14:49 Tx date 2024-03-27 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-235,469.806
-25,685 vol $9.17 each |
0 | |
| Filed 2024-03-28 14:47 Tx date 2024-03-27 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$235,469
+25,685 vol $9.17 each |
25,685 | |
| Filed 2024-03-25 15:43 Tx date 2024-03-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Mailling, Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$163,000
+20,000 vol $8.15 each |
85,000 | |
| Filed 2024-03-25 15:41 Tx date 2024-03-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,080,486
+132,575 vol $8.15 each |
535,809 | |
| Filed 2024-03-25 15:34 Tx date 2024-03-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Jacobs, Bryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$407,500
+50,000 vol $8.15 each |
212,109 | |
| Filed 2024-03-19 09:53 Tx date 2024-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,660
+606 vol $7.69 each |
363,761 | |
| Filed 2024-02-20 09:58 Tx date 2024-02-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,655
+667 vol $6.98 each |
363,155 | |
| Filed 2024-01-18 12:21 Tx date 2024-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,658
+795 vol $5.86 each |
362,488 | |
| Filed 2024-01-02 11:54 Tx date 2023-12-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-374,161.5072
-60,372 vol $6.20 each |
0 | |
| Filed 2024-01-02 11:52 Tx date 2023-12-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$374,161
+60,372 vol $6.20 each |
60,372 | |
| Filed 2023-12-20 12:55 Tx date 2023-12-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,591
+713 vol $6.44 each |
361,693 | |
| Filed 2023-12-01 15:20 Tx date 2023-11-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-180,983.4386
-29,819 vol $6.07 each |
0 | |
| Filed 2023-12-01 15:19 Tx date 2023-11-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$180,983
+29,819 vol $6.07 each |
29,819 | |
| Filed 2023-11-17 14:15 Tx date 2023-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,626
+883 vol $5.24 each |
360,980 | |
| Filed 2023-10-13 15:46 Tx date 2023-10-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-5,999,992.65
-1,290,321 vol $4.65 each |
0 | |
| Filed 2023-10-13 15:44 Tx date 2023-10-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$5,999,992
+1,290,321 vol $4.65 each |
1,290,321 | |
| Filed 2023-09-22 16:10 Tx date 2023-09-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,617
+1,026 vol $4.50 each |
359,015 | |
| Filed 2023-09-05 10:08 Tx date 2023-08-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-180,439.6272
-48,848 vol $3.69 each |
0 | |
| Filed 2023-09-05 10:06 Tx date 2023-08-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$180,439
+48,848 vol $3.69 each |
48,848 | |
| Filed 2023-08-17 12:54 Tx date 2023-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,615
+1,330 vol $3.47 each |
357,989 | |
| Filed 2023-07-18 13:30 Tx date 2023-07-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,635
+1,332 vol $3.48 each |
356,659 | |
| Filed 2023-07-04 12:03 Tx date 2023-06-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-235,979.757
-62,379 vol $3.78 each |
0 | |
| Filed 2023-07-04 12:01 Tx date 2023-06-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$235,979
+62,379 vol $3.78 each |
62,379 | |
| Filed 2023-06-30 15:07 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
2,500 | |
| Filed 2023-06-30 15:06 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-30 15:04 Tx date 2023-06-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$73,800
+20,000 vol $3.69 each |
25,000 | |
| Filed 2023-06-30 15:03 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
5,000 | |
| Filed 2023-06-30 15:02 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Walinski, Hubert
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-30 14:41 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
2,500 | |
| Filed 2023-06-30 14:38 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-30 14:37 Tx date 2023-06-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$73,800
+20,000 vol $3.69 each |
25,000 | |
| Filed 2023-06-30 14:35 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
5,000 | |
| Filed 2023-06-30 14:26 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deeth, Douglas Norman
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-06-26 16:59 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
12,876 | |
| Filed 2023-06-26 16:59 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
12,876 | |
| Filed 2023-06-26 16:57 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
42,521 | |
| Filed 2023-06-26 16:57 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
42,521 | |
| Filed 2023-06-26 16:54 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
296,831 | |
| Filed 2023-06-26 16:54 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
296,831 | |
| Filed 2023-06-26 16:47 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
403,234 | |
| Filed 2023-06-26 16:47 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
403,234 | |
| Filed 2023-06-16 09:59 Tx date 2023-06-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,586
+1,207 vol $3.80 each |
355,327 | |
| Filed 2023-06-06 10:50 Tx date 2023-05-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-98,498.841
-26,817 vol $3.67 each |
0 | |
| Filed 2023-06-06 10:48 Tx date 2023-05-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$98,498
+26,817 vol $3.67 each |
26,817 | |
| Filed 2023-05-17 11:45 Tx date 2023-04-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Mailling, Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$219,050
+65,000 vol $3.37 each |
65,000 | |
| Filed 2023-05-17 11:37 Tx date 2023-04-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Mailling, Ryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-15 13:17 Tx date 2023-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,263
+1,562 vol $3.37 each |
354,120 | |
| Filed 2023-04-22 21:37 Tx date 2023-04-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,012
+1,180 vol $3.40 each |
352,558 | |
| Filed 2023-04-10 10:03 Tx date 2023-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-28,986 vol |
0 | |
| Filed 2023-04-10 09:40 Tx date 2023-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$97,349
+28,986 vol $3.36 each |
28,986 | |
| Filed 2023-04-09 19:40 Tx date 2023-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-122,049 vol |
294,331 | |
| Filed 2023-04-09 19:39 Tx date 2023-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$440,596
+122,049 vol $3.61 each |
719,135 | |
| Filed 2023-04-09 19:28 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-7,500 vol |
5,376 | |
| Filed 2023-04-09 19:12 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
-7,500 vol |
||
| Filed 2023-04-09 19:08 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$28,125
+7,500 vol $3.75 each |
351,378 | |
| Filed 2023-04-09 19:02 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
14,376 | |
| Filed 2023-04-09 11:53 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
0 | |
| Filed 2023-04-09 11:50 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,375
+2,500 vol $3.75 each |
5,000 | |
| Filed 2023-04-09 11:43 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
0 | |
| Filed 2023-04-09 11:40 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,375
+2,500 vol $3.75 each |
91,710 | |
| Filed 2023-04-09 11:36 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
4,000 | |
| Filed 2023-04-09 11:19 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-24,602 vol |
41,705 | |
| Filed 2023-04-09 11:17 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,552 vol |
66,307 | |
| Filed 2023-04-09 11:16 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,065 vol |
67,859 | |
| Filed 2023-04-09 11:13 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$90,289
+24,602 vol $3.67 each |
84,036 | |
| Filed 2023-04-09 11:11 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,773
+1,552 vol $3.72 each |
59,434 | |
| Filed 2023-04-09 11:10 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$22,743
+6,065 vol $3.75 each |
57,882 | |
| Filed 2023-04-09 10:52 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
0 | |
| Filed 2023-04-09 10:38 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
4,000 | |
| Filed 2023-03-30 11:34 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,375
+2,500 vol $3.75 each |
251,540 | |
| Filed 2023-03-30 11:28 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$51,791
+14,112 vol $3.67 each |
597,086 | |
| Filed 2023-03-30 11:26 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$209,583
+55,889 vol $3.75 each |
582,974 | |
| Filed 2023-03-30 11:24 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-14,112 vol |
416,380 | |
| Filed 2023-03-30 11:22 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-55,889 vol |
430,492 | |
| Filed 2023-03-30 11:18 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$51,791
+14,112 vol $3.67 each |
527,085 | |
| Filed 2023-03-30 11:16 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$209,583
+55,889 vol $3.75 each |
512,973 | |
| Filed 2023-03-23 19:04 Tx date 2023-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+244,098 vol |
486,381 | |
| Filed 2023-03-23 18:50 Tx date 2023-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$662,966
+176,791 vol $3.75 each |
398,234 | |
| Filed 2023-03-23 17:45 Tx date 2023-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Jacobs, Bryan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+16,719 vol |
16,719 | |
| Filed 2023-03-23 17:39 Tx date 2022-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Jacobs, Bryan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-23 17:11 Tx date 2023-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,928 vol |
73,924 | |
| Filed 2023-03-23 16:11 Tx date 2023-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Jacobs, Bryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$45,408
+12,109 vol $3.75 each |
162,109 | |
| Filed 2023-03-23 15:19 Tx date 2023-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,668
+2,845 vol $3.75 each |
197,934 | |
| Filed 2023-03-21 14:49 Tx date 2023-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,620
+1,216 vol $3.80 each |
343,878 | |
| Filed 2023-03-16 08:24 Tx date 2022-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
97 - Other
|
+9,566,150 vol |
9,566,150 | |
| Filed 2023-03-16 08:22 Tx date 2019-03-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-03-16 08:19 Tx date 2022-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
97 - Other
|
-9,436,150 vol |
0 | |
| Filed 2023-02-21 13:56 Tx date 2023-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,617
+1,279 vol $3.61 each |
342,662 | |
| Filed 2023-01-18 15:38 Tx date 2023-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,636
+1,243 vol $3.73 each |
341,383 | |
| Filed 2023-01-10 13:38 Tx date 2022-12-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-45,610 vol |
0 | |
| Filed 2023-01-10 13:38 Tx date 2022-12-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$171,037
+45,610 vol $3.75 each |
45,610 | |
| Filed 2022-12-20 10:32 Tx date 2022-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,309
+1,105 vol $3.90 each |
340,140 | |
| Filed 2022-12-20 10:29 Tx date 2022-12-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-12,950
-3,500 vol $3.70 each |
89,210 | |
| Filed 2022-12-20 10:26 Tx date 2022-12-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,355
+3,500 vol $3.53 each |
92,710 | |
| Filed 2022-12-20 10:24 Tx date 2022-12-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,355
-3,500 vol $3.53 each |
34,021 | |
| Filed 2022-12-19 11:39 Tx date 2022-12-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,760
-6,000 vol $3.96 each |
89,210 | |
| Filed 2022-12-12 15:05 Tx date 2022-12-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,800
-4,000 vol $3.95 each |
95,210 | |
| Filed 2022-12-12 15:04 Tx date 2022-12-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,600
-4,000 vol $3.90 each |
99,210 | |
| Filed 2022-12-12 15:04 Tx date 2022-12-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-11,580
-3,000 vol $3.86 each |
103,210 | |
| Filed 2022-12-12 15:03 Tx date 2022-12-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-18,500
-5,000 vol $3.70 each |
106,210 | |
| Filed 2022-12-12 14:25 Tx date 2022-11-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-32,886 vol |
0 | |
| Filed 2022-12-12 14:25 Tx date 2022-11-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$113,127
+32,886 vol $3.44 each |
32,886 | |
| Filed 2022-11-17 10:56 Tx date 2022-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,318
+1,259 vol $3.43 each |
339,035 | |
| Filed 2022-11-16 14:25 Tx date 2022-11-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Jacobs, Bryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$16,500
+5,000 vol $3.30 each |
5,000 | |
| Filed 2022-11-16 14:24 Tx date 2022-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Jacobs, Bryan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-10-26 12:15 Tx date 2022-10-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,277
+1,407 vol $3.04 each |
337,776 | |
| Filed 2022-10-11 10:35 Tx date 2022-09-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-39,317 vol |
0 | |
| Filed 2022-10-11 10:34 Tx date 2022-09-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$127,387
+39,317 vol $3.24 each |
39,317 | |
| Filed 2022-09-19 11:44 Tx date 2022-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,569
+1,523 vol $3.00 each |
336,369 | |
| Filed 2022-09-19 11:42 Tx date 2022-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,077
+359 vol $3.00 each |
111,210 | |
| Filed 2022-09-06 12:42 Tx date 2022-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Jacobs, Bryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$346,500
+150,000 vol $2.31 each |
150,000 | |
| Filed 2022-09-06 12:36 Tx date 2022-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Jacobs, Bryan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-08-22 11:20 Tx date 2022-08-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,584
+2,002 vol $2.29 each |
334,846 | |
| Filed 2022-08-22 11:18 Tx date 2022-08-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,080
+472 vol $2.29 each |
110,851 | |
| Filed 2022-08-10 15:09 Tx date 2022-07-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-110,545 vol |
0 | |
| Filed 2022-08-10 15:09 Tx date 2022-07-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$244,304
+110,545 vol $2.21 each |
110,545 | |
| Filed 2022-07-18 12:53 Tx date 2022-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,020
+1,836 vol $2.19 each |
332,844 | |
| Filed 2022-07-18 12:51 Tx date 2022-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,079
+493 vol $2.19 each |
110,379 | |
| Filed 2022-07-12 14:51 Tx date 2022-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-123,000 vol |
0 | |
| Filed 2022-07-12 14:51 Tx date 2022-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$290,280
+123,000 vol $2.36 each |
123,000 | |
| Filed 2022-06-21 09:51 Tx date 2022-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,032
+1,716 vol $2.35 each |
331,008 | |
| Filed 2022-06-21 09:48 Tx date 2022-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,083
+461 vol $2.35 each |
109,886 | |
| Filed 2022-06-10 11:52 Tx date 2022-05-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-140,900 vol |
0 | |
| Filed 2022-06-10 11:52 Tx date 2022-05-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$332,524
+140,900 vol $2.36 each |
140,900 | |
| Filed 2022-05-26 11:29 Tx date 2022-05-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$917.39
+461 vol $1.99 each |
109,425 | |
| Filed 2022-05-26 11:27 Tx date 2022-05-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,414
+1,716 vol $1.99 each |
329,292 | |
| Filed 2022-05-10 12:02 Tx date 2022-04-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-137,400 vol |
0 | |
| Filed 2022-05-10 12:01 Tx date 2022-04-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$331,134
+137,400 vol $2.41 each |
137,400 | |
| Filed 2022-04-26 14:19 Tx date 2022-04-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$917.51
+439 vol $2.09 each |
108,964 | |
| Filed 2022-04-26 14:16 Tx date 2022-04-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,415
+1,634 vol $2.09 each |
327,576 | |
| Filed 2022-04-11 20:12 Tx date 2022-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-196,300 vol |
0 | |
| Filed 2022-04-11 20:12 Tx date 2022-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$429,897
+196,300 vol $2.19 each |
196,300 | |
| Filed 2022-04-04 19:19 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,552 vol |
69,996 | |
| Filed 2022-04-04 19:19 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-24,603 vol |
71,548 | |
| Filed 2022-04-04 19:18 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,243
+1,552 vol $2.09 each |
51,817 | |
| Filed 2022-04-04 19:17 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$55,356
+24,603 vol $2.25 each |
50,265 | |
| Filed 2022-04-04 19:15 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-7,500 vol |
5,376 | |
| Filed 2022-04-04 19:14 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,674
+7,500 vol $2.09 each |
325,942 | |
| Filed 2022-04-04 19:13 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
2,500 | |
| Filed 2022-04-04 19:12 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,225
+2,500 vol $2.09 each |
2,500 | |
| Filed 2022-04-04 19:12 Tx date 2020-10-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-04 19:10 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
242,283 | |
| Filed 2022-04-04 19:09 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-14,112 vol |
244,783 | |
| Filed 2022-04-04 19:08 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$31,752
+14,112 vol $2.25 each |
457,084 | |
| Filed 2022-04-04 19:08 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,225
+2,500 vol $2.09 each |
442,972 | |
| Filed 2022-04-04 19:05 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
0 | |
| Filed 2022-04-04 19:05 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,225
+2,500 vol $2.09 each |
249,040 | |
| Filed 2022-04-04 19:03 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
0 | |
| Filed 2022-04-04 19:02 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,225
+2,500 vol $2.09 each |
108,525 | |
| Filed 2022-04-04 18:57 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,500 vol |
5,000 | |
| Filed 2022-04-04 18:55 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$5,225
+2,500 vol $2.09 each |
490,355 | |
| Filed 2022-03-30 14:46 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+18,546 vol |
18,546 | |
| Filed 2022-03-30 14:45 Tx date 2020-07-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-03-30 14:44 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$5,952
+2,743 vol $2.17 each |
52,743 | |
| Filed 2022-03-30 14:40 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+24,260 vol |
96,151 | |
| Filed 2022-03-30 14:39 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,452
+47,674 vol $2.17 each |
195,089 | |
| Filed 2022-03-30 14:37 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
5,000 | |
| Filed 2022-03-30 14:36 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,850
+5,000 vol $2.17 each |
30,000 | |
| Filed 2022-03-30 14:33 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+216,059 vol |
258,895 | |
| Filed 2022-03-30 14:31 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$341,866
+157,542 vol $2.17 each |
221,443 | |
| Filed 2022-03-30 14:28 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
2,500 | |
| Filed 2022-03-30 14:27 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,850
+5,000 vol $2.17 each |
34,021 | |
| Filed 2022-03-30 14:25 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
12,876 | |
| Filed 2022-03-30 14:24 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,850
+5,000 vol $2.17 each |
37,521 | |
| Filed 2022-03-30 14:21 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
2,500 | |
| Filed 2022-03-30 14:20 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,850
+5,000 vol $2.17 each |
37,521 | |
| Filed 2022-03-30 14:17 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
$10,850
+5,000 vol $2.17 each |
7,500 | |
| Filed 2022-03-30 14:10 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,500 vol |
2,500 | |
| Filed 2022-03-21 13:34 Tx date 2022-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,415
+2,070 vol $1.65 each |
318,442 | |
| Filed 2022-03-11 12:34 Tx date 2022-02-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-136,500 vol |
0 | |
| Filed 2022-03-11 12:33 Tx date 2022-02-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$282,555
+136,500 vol $2.07 each |
136,500 | |
| Filed 2022-02-20 12:54 Tx date 2022-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,415
+1,908 vol $1.79 each |
316,372 | |
| Filed 2022-02-11 15:07 Tx date 2022-01-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-130,300 vol |
0 | |
| Filed 2022-02-11 15:06 Tx date 2022-01-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$233,237
+130,300 vol $1.79 each |
130,300 | |
| Filed 2022-01-20 17:00 Tx date 2022-01-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,115
+5,121 vol $1.78 each |
314,464 | |
| Filed 2022-01-10 14:36 Tx date 2021-12-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-156,200 vol |
0 | |
| Filed 2022-01-10 14:22 Tx date 2021-12-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$279,598
+156,200 vol $1.79 each |
156,200 | |
| Filed 2021-12-14 14:18 Tx date 2021-11-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-161,200 vol |
0 | |
| Filed 2021-12-14 14:16 Tx date 2021-11-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$375,596
+161,200 vol $2.33 each |
161,200 | |
| Filed 2021-11-18 10:01 Tx date 2021-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,563
+1,967 vol $2.32 each |
309,343 | |
| Filed 2021-11-10 14:08 Tx date 2021-10-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-132,800 vol |
0 | |
| Filed 2021-11-10 14:07 Tx date 2021-10-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$333,328
+132,800 vol $2.51 each |
132,800 | |
| Filed 2021-10-20 11:54 Tx date 2021-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,551
+1,828 vol $2.49 each |
307,376 | |
| Filed 2021-10-13 10:40 Tx date 2021-09-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-116,300 vol |
0 | |
| Filed 2021-10-13 10:38 Tx date 2021-09-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$286,098
+116,300 vol $2.46 each |
116,300 | |
| Filed 2021-09-20 16:46 Tx date 2021-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,552
+1,881 vol $2.42 each |
305,548 | |
| Filed 2021-09-13 12:40 Tx date 2021-08-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-40,500 vol |
0 | |
| Filed 2021-09-13 12:38 Tx date 2021-08-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$58,684
+36,450 vol $1.61 each |
40,500 | |
| Filed 2021-09-13 12:36 Tx date 2021-08-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$6,520
+4,050 vol $1.61 each |
4,050 | |
| Filed 2021-08-20 11:15 Tx date 2021-08-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,570
+2,320 vol $1.97 each |
303,667 | |
| Filed 2021-08-13 09:55 Tx date 2021-07-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$-121,317
-76,300 vol $1.59 each |
0 | |
| Filed 2021-08-13 09:53 Tx date 2021-07-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$121,317
+76,300 vol $1.59 each |
76,300 | |
| Filed 2021-07-27 12:43 Tx date 2021-07-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,548
+2,808 vol $1.62 each |
301,347 | |
| Filed 2021-07-27 12:41 Tx date 2021-07-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,056
+652 vol $1.62 each |
106,025 | |
| Filed 2021-07-13 10:54 Tx date 2021-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-145,900 vol |
0 | |
| Filed 2021-07-13 10:53 Tx date 2021-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$230,522
+145,900 vol $1.58 each |
145,900 | |
| Filed 2021-06-22 12:38 Tx date 2021-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,875
+2,768 vol $1.40 each |
298,539 | |
| Filed 2021-06-21 11:56 Tx date 2021-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$900.20
+643 vol $1.40 each |
105,373 | |
| Filed 2021-06-11 11:39 Tx date 2021-05-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-102,000 vol |
0 | |
| Filed 2021-06-11 11:37 Tx date 2021-05-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$141,780
+102,000 vol $1.39 each |
102,000 | |
| Filed 2021-06-04 11:52 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-24,603 vol |
71,891 | |
| Filed 2021-06-04 11:48 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-15,613 vol |
42,836 | |
| Filed 2021-06-04 10:43 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2021-06-04 10:39 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
5,376 | |
| Filed 2021-06-04 10:36 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2021-06-04 10:34 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2021-05-28 14:40 Tx date 2021-05-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,578
+3,202 vol $1.43 each |
295,771 | |
| Filed 2021-05-28 14:38 Tx date 2021-05-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,063
+744 vol $1.43 each |
104,730 | |
| Filed 2021-05-26 10:23 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$25,833
+24,603 vol $1.05 each |
25,662 | |
| Filed 2021-05-26 10:21 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,575
+1,500 vol $1.05 each |
289,199 | |
| Filed 2021-05-26 10:19 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,575
+1,500 vol $1.05 each |
80,204 | |
| Filed 2021-05-26 10:17 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,575
+1,500 vol $1.05 each |
246,540 | |
| Filed 2021-05-26 09:41 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,393
+15,613 vol $1.05 each |
440,472 | |
| Filed 2021-05-26 09:37 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,575
+1,500 vol $1.05 each |
487,855 | |
| Filed 2021-05-11 10:27 Tx date 2021-04-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-129,400 vol |
0 | |
| Filed 2021-05-11 10:25 Tx date 2021-04-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$173,396
+129,400 vol $1.34 each |
129,400 | |
| Filed 2021-04-26 17:51 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,500
+5,000 vol $0.90 each |
25,000 | |
| Filed 2021-04-23 10:25 Tx date 2021-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,549
+3,370 vol $1.35 each |
291,069 | |
| Filed 2021-04-23 10:22 Tx date 2021-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,055
+782 vol $1.35 each |
102,486 | |
| Filed 2021-04-15 17:32 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+2,500 vol |
2,500 | |
| Filed 2021-04-15 17:27 Tx date 2020-10-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-04-01 19:43 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,125
+1,250 vol $0.90 each |
||
| Filed 2021-04-13 17:05 Tx date 2021-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-18,200 vol |
0 | |
| Filed 2021-04-13 17:04 Tx date 2021-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$23,660
+18,200 vol $1.30 each |
18,200 | |
| Filed 2021-04-01 19:43 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,125
+1,250 vol $0.90 each |
21,250 | |
| Filed 2021-03-26 14:41 Tx date 2021-03-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,720
+4,000 vol $1.18 each |
101,704 | |
| Filed 2021-03-26 09:54 Tx date 2021-03-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$31,250
+25,000 vol $1.25 each |
25,000 | |
| Filed 2021-03-26 09:52 Tx date 2020-07-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-25 13:41 Tx date 2021-03-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,770
+7,000 vol $1.11 each |
97,704 | |
| Filed 2021-03-25 13:40 Tx date 2021-03-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,880
+12,000 vol $1.24 each |
90,704 | |
| Filed 2021-03-16 12:51 Tx date 2021-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,589
+5,099 vol $0.90 each |
287,699 | |
| Filed 2021-03-16 12:48 Tx date 2021-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,065
+1,184 vol $0.90 each |
78,704 | |
| Filed 2021-03-05 14:13 Tx date 2021-01-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-132,000 vol |
0 | |
| Filed 2021-03-05 14:13 Tx date 2020-12-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$115,090
+132,000 vol $0.87 each |
132,000 | |
| Filed 2021-03-05 12:05 Tx date 2020-11-27 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-73,500 vol |
0 | |
| Filed 2021-03-05 12:04 Tx date 2020-11-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$68,840
+73,500 vol $0.94 each |
73,500 | |
| Filed 2021-03-05 11:55 Tx date 2020-09-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
-30,000 vol |
0 | |
| Filed 2021-03-05 11:54 Tx date 2020-09-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
38 - Redemption, retraction, cancellation, repurchase
|
$34,038
+30,000 vol $1.13 each |
30,000 | |
| Filed 2021-03-05 11:51 Tx date 2004-01-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Cipher Pharmaceuticals Inc.
1 - Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-22 11:03 Tx date 2021-02-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,875
+4,726 vol $0.82 each |
282,600 | |
| Filed 2021-02-22 11:00 Tx date 2021-02-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$899.54
+1,097 vol $0.82 each |
77,520 | |
| Filed 2021-01-25 10:51 Tx date 2021-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,576
+4,123 vol $1.11 each |
277,874 | |
| Filed 2021-01-25 10:48 Tx date 2021-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,062
+957 vol $1.11 each |
76,423 | |
| Filed 2020-12-17 15:10 Tx date 2020-12-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,927
+5,455 vol $0.72 each |
273,751 | |
| Filed 2020-12-17 15:07 Tx date 2020-12-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$888.48
+1,234 vol $0.72 each |
75,466 | |
| Filed 2020-12-01 15:18 Tx date 2020-12-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,480
+4,000 vol $0.87 each |
74,232 | |
| Filed 2020-11-19 11:40 Tx date 2020-11-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,600
+20,000 vol $0.93 each |
20,000 | |
| Filed 2020-11-19 11:36 Tx date 2020-10-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Steiner, Cathy Robin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-19 09:31 Tx date 2020-11-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$4,999
+5,376 vol $0.93 each |
6,876 | |
| Filed 2020-11-17 10:20 Tx date 2020-11-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,936
+4,860 vol $0.81 each |
268,296 | |
| Filed 2020-11-17 10:16 Tx date 2020-11-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$888.57
+1,097 vol $0.81 each |
70,232 | |
| Filed 2020-11-11 22:47 Tx date 2020-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,151
+3,426 vol $0.92 each |
263,436 | |
| Filed 2020-11-11 22:45 Tx date 2020-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$860.20
+935 vol $0.92 each |
69,135 | |
| Filed 2020-09-18 14:48 Tx date 2020-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,881
+3,961 vol $0.98 each |
260,010 | |
| Filed 2020-09-18 14:44 Tx date 2020-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$901.60
+920 vol $0.98 each |
68,200 | |
| Filed 2020-09-08 13:46 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+829 vol |
424,859 | |
| Filed 2020-05-29 16:53 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+806 vol |
||
| Filed 2020-08-19 10:50 Tx date 2020-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,552
+6,625 vol $1.14 each |
256,049 | |
| Filed 2020-08-19 10:42 Tx date 2020-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,790
+1,571 vol $1.14 each |
67,280 | |
| Filed 2020-08-17 15:15 Tx date 2020-08-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
56 - Grant of rights
|
$250.00
+25,000 vol $0.01 each |
50,000 | |
| Filed 2020-08-17 14:44 Tx date 2020-08-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$35,750
+25,000 vol $1.43 each |
25,000 | |
| Filed 2020-08-17 14:36 Tx date 2020-07-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Langille, Scott
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-06-25 23:07 Tx date 2020-06-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-13,604.76
-11,934 vol $1.14 each |
0 | |
| Filed 2020-06-16 14:16 Tx date 2020-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,587
+3,552 vol $1.01 each |
249,424 | |
| Filed 2020-06-16 14:14 Tx date 2020-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$869.61
+861 vol $1.01 each |
65,709 | |
| Filed 2020-05-29 16:53 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+806 vol |
424,836 | |
| Filed 2020-05-29 16:52 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
58,449 | |
| Filed 2020-05-29 16:51 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+478 vol |
486,355 | |
| Filed 2020-05-29 16:50 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-866 vol |
1,500 | |
| Filed 2020-05-29 16:49 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+866 vol |
64,848 | |
| Filed 2020-05-29 16:48 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-866 vol |
1,500 | |
| Filed 2020-05-29 16:46 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,059 vol |
1,059 | |
| Filed 2020-05-29 16:46 Tx date 2018-06-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-29 16:45 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,916 vol |
96,494 | |
| Filed 2020-05-29 16:41 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+478 vol |
245,040 | |
| Filed 2020-05-29 16:40 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-866 vol |
1,500 | |
| Filed 2020-05-29 16:35 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+478 vol |
245,872 | |
| Filed 2020-05-29 16:34 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-866 vol |
1,500 | |
| Filed 2020-05-29 16:32 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,810 vol |
11,934 | |
| Filed 2020-05-29 16:31 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,891 vol |
98,632 | |
| Filed 2020-05-20 16:40 Tx date 2020-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,632
+3,427 vol $1.06 each |
245,394 | |
| Filed 2020-05-20 16:37 Tx date 2020-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$881.92
+832 vol $1.06 each |
63,982 | |
| Filed 2020-05-11 17:00 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
59,949 | |
| Filed 2020-05-11 16:58 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,150
+3,500 vol $0.90 each |
63,901 | |
| Filed 2020-05-11 16:46 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
2,366 | |
| Filed 2020-05-11 16:44 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,150
+3,500 vol $0.90 each |
29,021 | |
| Filed 2020-05-11 16:42 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
2,366 | |
| Filed 2020-05-11 16:32 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,150
+3,500 vol $0.90 each |
32,521 | |
| Filed 2020-05-11 16:29 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
2,366 | |
| Filed 2020-05-11 16:21 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,150
+3,500 vol $0.90 each |
32,521 | |
| Filed 2020-05-11 16:19 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
2,366 | |
| Filed 2020-05-11 16:16 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,150
+3,500 vol $0.90 each |
35,021 | |
| Filed 2020-04-21 09:23 Tx date 2020-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$883.50
+1,425 vol $0.62 each |
63,150 | |
| Filed 2020-04-21 09:22 Tx date 2020-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,646
+5,882 vol $0.62 each |
241,967 | |
| Filed 2020-04-21 09:19 Tx date 2020-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$912.64
+1,472 vol $0.62 each |
||
| Filed 2020-04-21 09:18 Tx date 2020-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$912.64
+1,472 vol $0.62 each |
||
| Filed 2020-04-12 10:32 Tx date 2020-04-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+56,449 vol |
58,449 | |
| Filed 2020-04-12 10:31 Tx date 2020-04-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$29,088
+40,401 vol $0.72 each |
60,401 | |
| Filed 2020-04-12 10:28 Tx date 2020-04-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+90,747 vol |
98,410 | |
| Filed 2020-04-12 10:27 Tx date 2020-04-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,669
+64,819 vol $0.72 each |
147,415 | |
| Filed 2020-04-12 10:24 Tx date 2020-04-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+82,934 vol |
105,523 | |
| Filed 2020-04-12 10:20 Tx date 2020-04-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$42,652
+59,239 vol $0.72 each |
114,538 | |
| Filed 2020-03-18 11:46 Tx date 2020-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,637
+6,062 vol $0.60 each |
236,085 | |
| Filed 2020-03-18 11:44 Tx date 2020-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$883.20
+1,472 vol $0.60 each |
61,725 | |
| Filed 2020-02-21 15:58 Tx date 2020-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,632
+4,224 vol $0.86 each |
230,023 | |
| Filed 2020-02-21 15:57 Tx date 2020-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$882.36
+1,026 vol $0.86 each |
60,253 | |
| Filed 2020-01-20 09:44 Tx date 2020-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,615
+3,411 vol $1.06 each |
225,799 | |
| Filed 2020-01-20 09:43 Tx date 2020-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$882.98
+833 vol $1.06 each |
59,227 | |
| Filed 2019-12-16 08:19 Tx date 2019-12-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,906
+4,651 vol $0.84 each |
222,388 | |
| Filed 2019-12-16 08:16 Tx date 2019-12-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$882.00
+1,050 vol $0.84 each |
58,394 | |
| Filed 2019-11-18 16:40 Tx date 2019-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,907
+3,757 vol $1.04 each |
217,737 | |
| Filed 2019-11-18 16:39 Tx date 2019-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$881.92
+848 vol $1.04 each |
57,344 | |
| Filed 2019-10-25 17:14 Tx date 2019-10-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,719
+3,476 vol $1.07 each |
213,980 | |
| Filed 2019-10-25 17:13 Tx date 2019-10-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$880.61
+823 vol $1.07 each |
56,496 | |
| Filed 2019-09-25 10:08 Tx date 2019-09-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,629
+2,975 vol $1.22 each |
210,504 | |
| Filed 2019-09-25 10:08 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,637
+3,566 vol $1.02 each |
207,529 | |
| Filed 2019-09-25 10:05 Tx date 2019-09-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$880.84
+722 vol $1.22 each |
55,673 | |
| Filed 2019-09-25 10:04 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$881.28
+864 vol $1.02 each |
51,951 | |
| Filed 2019-08-26 16:19 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$449.82
+441 vol $1.02 each |
||
| Filed 2019-08-26 15:42 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,279
+3,566 vol $1.20 each |
||
| Filed 2019-08-26 16:19 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$449.82
+441 vol $1.02 each |
51,528 | |
| Filed 2019-08-26 15:42 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,279
+3,566 vol $1.20 each |
207,529 | |
| Filed 2019-08-24 22:33 Tx date 2019-08-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,674
+24,800 vol $0.95 each |
244,562 | |
| Filed 2019-08-24 22:30 Tx date 2019-08-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,492
+11,200 vol $0.94 each |
219,762 | |
| Filed 2019-08-24 22:29 Tx date 2019-08-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,046
+18,200 vol $0.94 each |
208,562 | |
| Filed 2019-08-24 22:28 Tx date 2019-08-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,015
+18,000 vol $0.95 each |
190,362 | |
| Filed 2019-08-21 17:19 Tx date 2019-08-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,704
+17,300 vol $1.20 each |
172,362 | |
| Filed 2019-08-21 17:18 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$59,200
+50,000 vol $1.18 each |
155,062 | |
| Filed 2019-08-19 14:07 Tx date 2019-08-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,600
+3,000 vol $1.20 each |
54,087 | |
| Filed 2019-08-09 12:09 Tx date 2019-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,000 vol |
2,000 | |
| Filed 2019-08-09 12:07 Tx date 2019-03-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-09 12:01 Tx date 2019-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$23,600
+20,000 vol $1.18 each |
20,000 | |
| Filed 2019-08-09 11:58 Tx date 2019-03-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-07-22 20:27 Tx date 2019-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,385
+3,255 vol $1.04 each |
203,963 | |
| Filed 2019-07-22 20:25 Tx date 2019-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$869.44
+836 vol $1.04 each |
51,087 | |
| Filed 2019-06-28 09:50 Tx date 2019-06-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,960
+3,000 vol $1.32 each |
50,251 | |
| Filed 2019-06-21 13:19 Tx date 2019-06-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,479
+7,262 vol $1.03 each |
200,708 | |
| Filed 2019-06-21 13:14 Tx date 2019-06-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,707
+1,658 vol $1.03 each |
43,251 | |
| Filed 2019-06-20 13:36 Tx date 2019-06-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,680
+4,000 vol $1.17 each |
45,593 | |
| Filed 2019-04-26 09:02 Tx date 2019-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
2,366 | |
| Filed 2019-04-26 08:55 Tx date 2019-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+2,021 vol |
29,021 | |
| Filed 2019-04-23 22:30 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
866 | |
| Filed 2019-04-23 22:29 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
866 | |
| Filed 2019-04-23 22:28 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+948 vol |
948 | |
| Filed 2019-04-23 22:27 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,663 vol |
7,663 | |
| Filed 2019-04-23 22:26 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+25,450 vol |
47,461 | |
| Filed 2019-04-23 22:25 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+55,973 vol |
96,697 | |
| Filed 2019-04-23 22:24 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
866 | |
| Filed 2019-04-23 22:23 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,991
+2,021 vol $1.48 each |
25,521 | |
| Filed 2019-04-23 22:22 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
866 | |
| Filed 2019-04-23 22:21 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,991
+2,021 vol $1.48 each |
22,021 | |
| Filed 2019-04-23 22:19 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+12,846 vol |
22,589 | |
| Filed 2019-04-23 22:19 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
866 | |
| Filed 2019-04-23 22:18 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,991
+2,021 vol $1.48 each |
29,021 | |
| Filed 2019-04-23 22:16 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+866 vol |
||
| Filed 2019-04-23 22:14 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,991
+2,021 vol $1.48 each |
29,021 | |
| Filed 2019-04-23 22:12 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+866 vol |
||
| Filed 2019-04-23 22:11 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,991
+2,021 vol $1.48 each |
31,521 | |
| Filed 2019-04-23 18:51 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+948 vol |
948 | |
| Filed 2019-04-23 18:51 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+948 vol |
||
| Filed 2019-04-23 18:50 Tx date 2018-12-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-23 18:50 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$4,916
+3,322 vol $1.48 each |
43,322 | |
| Filed 2019-04-23 18:48 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+7,663 vol |
||
| Filed 2019-04-23 18:48 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+7,663 vol |
7,663 | |
| Filed 2019-04-23 18:48 Tx date 2018-06-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-23 18:47 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$39,745
+26,855 vol $1.48 each |
82,596 | |
| Filed 2019-04-23 18:46 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+25,450 vol |
||
| Filed 2019-04-23 18:46 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+25,450 vol |
47,461 | |
| Filed 2019-04-23 18:45 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$56,574
+38,226 vol $1.48 each |
114,221 | |
| Filed 2019-04-23 18:44 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+55,973 vol |
96,697 | |
| Filed 2019-04-23 18:44 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+55,973 vol |
||
| Filed 2019-04-23 18:42 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$290,327
+196,167 vol $1.48 each |
484,181 | |
| Filed 2019-04-23 17:57 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$290,327
+196,167 vol $1.48 each |
||
| Filed 2019-04-23 17:57 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$290,327
+196,167 vol $1.48 each |
484,181 | |
| Filed 2019-04-23 17:55 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+12,846 vol |
||
| Filed 2019-04-23 17:55 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+12,846 vol |
22,589 | |
| Filed 2019-04-23 17:54 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$28,556
+19,295 vol $1.48 each |
55,299 | |
| Filed 2019-04-18 11:56 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$100.28
+92 vol $1.09 each |
8,124 | |
| Filed 2019-04-18 11:55 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$500.31
+459 vol $1.09 each |
8,073 | |
| Filed 2019-04-18 11:54 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,522
+3,232 vol $1.09 each |
193,446 | |
| Filed 2019-04-18 11:52 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$820.77
+753 vol $1.09 each |
41,593 | |
| Filed 2019-04-18 10:31 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,077.48
-738 vol $1.46 each |
94,922 | |
| Filed 2019-04-18 10:31 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,077.48
-738 vol $1.46 each |
94,922 | |
| Filed 2019-04-18 10:27 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
95,660 | |
| Filed 2019-04-18 10:27 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
95,660 | |
| Filed 2019-04-18 10:24 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-18 10:24 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-18 10:13 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,946
+4,538 vol $1.09 each |
99,460 | |
| Filed 2019-04-18 10:13 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,946
+4,538 vol $1.09 each |
99,460 | |
| Filed 2019-04-17 13:26 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,596 vol |
8,032 | |
| Filed 2019-04-17 13:26 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,102 vol |
9,743 | |
| Filed 2019-04-17 13:11 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
190,214 | |
| Filed 2019-04-17 13:10 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 13:09 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,635 vol |
7,614 | |
| Filed 2019-04-17 13:08 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-5,187 vol |
22,011 | |
| Filed 2019-04-17 13:06 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+7,593 vol |
44,606 | |
| Filed 2019-04-17 13:04 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-14,947 vol |
40,724 | |
| Filed 2019-04-17 12:53 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+741 vol |
741 | |
| Filed 2019-04-17 12:53 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+741 vol |
||
| Filed 2019-04-17 12:52 Tx date 2018-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-04-17 12:42 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 12:40 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+762 vol |
485,877 | |
| Filed 2019-04-17 12:37 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 12:36 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+762 vol |
40,840 | |
| Filed 2019-04-17 12:35 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 12:32 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 11:54 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
||
| Filed 2019-04-17 11:54 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
41,578 | |
| Filed 2019-04-17 11:53 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2019-04-17 11:53 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 11:46 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2019-04-17 11:46 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2019-04-17 11:45 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+762 vol |
105,062 | |
| Filed 2019-04-17 11:43 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2019-04-17 11:43 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2019-04-02 21:05 Tx date 2019-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,436 | ||
| Filed 2019-04-02 20:56 Tx date 2019-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
14,845 | ||
| Filed 2019-04-02 20:54 Tx date 2019-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Jutlah, Nadine
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
36,004 | ||
| Filed 2019-04-01 Tx date 2019-03-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, Craig
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
424,030 | ||
| Filed 2019-03-20 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,040
+3,231 vol $1.56 each |
94,160 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.20
+320 vol $1.56 each |
4,979 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,625
+2,324 vol $1.56 each |
188,714 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$299.52
+192 vol $1.56 each |
24,550 | |
| Filed 2019-03-19 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$847.08
+543 vol $1.56 each |
40,078 | |
| Filed 2019-02-20 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,053
+3,139 vol $1.61 each |
90,929 | |
| Filed 2019-02-19 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$299.46
+186 vol $1.61 each |
24,358 | |
| Filed 2019-02-19 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$500.71
+311 vol $1.61 each |
4,659 | |
| Filed 2019-02-19 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,632
+2,256 vol $1.61 each |
186,390 | |
| Filed 2019-02-19 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$846.86
+526 vol $1.61 each |
39,535 | |
| Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.95
+303 vol $1.65 each |
4,348 | |
| Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,012
+3,038 vol $1.65 each |
87,790 | |
| Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$846.45
+513 vol $1.65 each |
39,009 | |
| Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,611
+2,189 vol $1.65 each |
184,134 | |
| Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+765 vol $1.65 each |
24,172 | |
| Filed 2018-12-21 Tx date 2018-12-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$85,000
+50,000 vol $1.70 each |
485,115 | |
| Filed 2018-12-21 Tx date 2018-12-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$68,000
+40,000 vol $1.70 each |
435,115 | |
| Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.81
+331 vol $1.51 each |
4,045 | |
| Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,871
+2,564 vol $1.51 each |
181,945 | |
| Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$892.41
+591 vol $1.51 each |
38,496 | |
| Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+836 vol $1.51 each |
23,407 | |
| Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,392
+3,571 vol $1.51 each |
84,752 | |
| Filed 2018-12-20 Tx date 2018-12-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,100
+10,000 vol $1.71 each |
395,115 | |
| Filed 2018-12-18 Tx date 2018-12-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$70,000
+40,000 vol $1.75 each |
40,000 | |
| Filed 2018-12-18 Tx date 2018-12-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Milloy, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,398
+3,575 vol $1.51 each |
81,181 | |
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,873
+2,565 vol $1.51 each |
179,381 | |
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+836 vol $1.51 each |
||
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$845.60
+560 vol $1.51 each |
37,905 | |
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.81
+331 vol $1.51 each |
3,714 | |
| Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+836 vol $1.51 each |
22,571 | |
| Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+495 vol $2.55 each |
21,735 | |
| Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.80
+196 vol $2.55 each |
3,383 | |
| Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,886
+1,524 vol $2.55 each |
176,816 | |
| Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$846.60
+332 vol $2.55 each |
37,345 | |
| Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,398
+2,117 vol $2.55 each |
77,606 | |
| Filed 2018-09-20 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,395
+1,934 vol $2.79 each |
75,489 | |
| Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$463.61
+179 vol $2.59 each |
||
| Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$845.37
+303 vol $2.79 each |
37,013 | |
| Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.41
+179 vol $2.79 each |
3,187 | |
| Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,674
+1,317 vol $2.79 each |
175,292 | |
| Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,263
+453 vol $2.79 each |
21,240 | |
| Filed 2018-08-28 Tx date 2018-08-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,151 vol |
3,008 | |
| Filed 2018-08-28 Tx date 2018-08-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,151 vol |
27,198 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$844.34
+326 vol $2.59 each |
36,710 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,394
+2,083 vol $2.59 each |
73,555 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,263
+488 vol $2.59 each |
20,787 | |
| Filed 2018-08-20 Tx date 2018-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-20 Tx date 2018-08-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,800
+20,000 vol $3.04 each |
20,000 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,623
+1,399 vol $2.59 each |
173,975 | |
| Filed 2018-08-20 Tx date 2018-08-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.87
+193 vol $2.59 each |
857 | |
| Filed 2018-08-20 Tx date 2018-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Terrisse-Rulleau, Laurence
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-08-15 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,600
+2,000 vol $2.80 each |
36,384 | |
| Filed 2018-08-14 Tx date 2018-08-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$169,452
+55,741 vol $3.04 each |
55,741 | |
| Filed 2018-08-14 Tx date 2018-06-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Gajewczyk, Diane
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-20 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,416
+2,276 vol $2.38 each |
71,472 | |
| Filed 2018-07-19 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$499.80
+210 vol $2.38 each |
664 | |
| Filed 2018-07-19 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,261
+530 vol $2.38 each |
20,299 | |
| Filed 2018-07-19 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$844.90
+355 vol $2.38 each |
34,384 | |
| Filed 2018-07-19 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,619
+1,521 vol $2.38 each |
172,576 | |
| Filed 2018-07-05 Tx date 2018-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-3,582 vol |
23,216 | |
| Filed 2018-07-05 Tx date 2018-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$9,993
+3,582 vol $2.79 each |
19,769 | |
| Filed 2018-07-02 Tx date 2018-06-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,620
+7,800 vol $2.90 each |
385,115 | |
| Filed 2018-06-28 Tx date 2018-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,000
+10,000 vol $2.80 each |
377,315 | |
| Filed 2018-06-26 Tx date 2018-06-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,050
+2,200 vol $2.75 each |
367,315 | |
| Filed 2018-06-22 Tx date 2018-06-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,700
+2,000 vol $2.85 each |
34,029 | |
| Filed 2018-06-21 Tx date 2018-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,700
+2,000 vol $2.85 each |
32,029 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,263
+547 vol $2.31 each |
16,187 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$845.46
+366 vol $2.31 each |
30,029 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,128
+2,220 vol $2.31 each |
69,196 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$498.96
+216 vol $2.31 each |
454 | |
| Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,640
+1,576 vol $2.31 each |
171,055 | |
| Filed 2018-06-08 Tx date 2018-06-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,430
+2,000 vol $2.71 each |
29,663 | |
| Filed 2018-06-05 Tx date 2018-06-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,100
+2,000 vol $3.05 each |
27,663 | |
| Filed 2018-05-21 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$498.96
+168 vol $2.97 each |
238 | |
| Filed 2018-05-21 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$778.14
+262 vol $2.97 each |
20,663 | |
| Filed 2018-05-21 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,356
+1,130 vol $2.97 each |
169,479 | |
| Filed 2018-05-21 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,262
+425 vol $2.97 each |
15,640 | |
| Filed 2018-05-18 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,754
+1,601 vol $2.97 each |
66,976 | |
| Filed 2018-05-17 Tx date 2018-05-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$17,925
+5,000 vol $3.58 each |
25,401 | |
| Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$250.60
+70 vol $3.58 each |
70 | |
| Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,622
+1,012 vol $3.58 each |
168,349 | |
| Filed 2018-04-20 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,263
+353 vol $3.58 each |
15,215 | |
| Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$844.88
+236 vol $3.58 each |
20,401 | |
| Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,029
+1,405 vol $3.58 each |
65,375 | |
| Filed 2018-04-08 Tx date 2018-04-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2018-04-08 Tx date 2018-04-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
63,970 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-4,769 vol |
43,678 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-4,769 vol |
||
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,582 vol |
14,862 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,769 vol |
11,280 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$17,025
+4,769 vol $3.57 each |
||
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
20,165 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-4,113 vol |
55,671 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
104,300 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
167,337 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,582 vol |
40,096 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,113 vol |
37,013 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
365,115 | |
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2018-03-28 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2018-03-28 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,355
+3,500 vol $3.53 each |
29,500 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,355
+3,500 vol $3.53 each |
27,000 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,745 vol |
29,349 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,745 vol |
||
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$143,406
+40,625 vol $3.53 each |
75,995 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$143,406
+40,625 vol $3.53 each |
||
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+43,334 vol |
59,784 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$698,989
+198,014 vol $3.53 each |
288,014 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+22,213 vol |
48,447 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$358,295
+101,500 vol $3.53 each |
226,544 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,355
+3,500 vol $3.53 each |
27,000 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,355
+3,500 vol $3.53 each |
23,500 | |
| Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,355
+3,500 vol $3.53 each |
27,000 | |
| Filed 2018-03-23 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$181,500
+50,000 vol $3.63 each |
165,837 | |
| Filed 2018-03-23 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,190
+13,000 vol $3.63 each |
18,665 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$845.00
+250 vol $3.38 each |
5,665 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,029
+1,488 vol $3.38 each |
62,470 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,206
+357 vol $3.38 each |
6,511 | |
| Filed 2018-03-20 Tx date 2018-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,623
+1,072 vol $3.38 each |
115,837 | |
| Filed 2018-02-20 Tx date 2018-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,023
+1,469 vol $3.42 each |
60,982 | |
| Filed 2018-02-20 Tx date 2018-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,207
+353 vol $3.42 each |
6,154 | |
| Filed 2018-02-20 Tx date 2018-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,621
+1,059 vol $3.42 each |
114,765 | |
| Filed 2018-02-20 Tx date 2018-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$844.74
+247 vol $3.42 each |
5,415 | |
| Filed 2018-01-19 Tx date 2018-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,995
+1,350 vol $3.70 each |
59,513 | |
| Filed 2018-01-17 Tx date 2018-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,607
+975 vol $3.70 each |
113,706 | |
| Filed 2018-01-17 Tx date 2018-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,206
+326 vol $3.70 each |
5,801 | |
| Filed 2018-01-17 Tx date 2018-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$847.30
+229 vol $3.70 each |
5,168 | |
| Filed 2017-12-20 Tx date 2017-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,373
+1,357 vol $3.96 each |
58,163 | |
| Filed 2017-12-19 Tx date 2017-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,864
+976 vol $3.96 each |
112,731 | |
| Filed 2017-12-19 Tx date 2017-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$784.08
+198 vol $3.96 each |
4,939 | |
| Filed 2017-12-19 Tx date 2017-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,207
+305 vol $3.96 each |
5,475 | |
| Filed 2017-11-19 Tx date 2017-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,376
+1,393 vol $3.86 each |
56,806 | |
| Filed 2017-11-17 Tx date 2017-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,208
+313 vol $3.86 each |
5,170 | |
| Filed 2017-11-17 Tx date 2017-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$841.48
+218 vol $3.86 each |
4,741 | |
| Filed 2017-11-17 Tx date 2017-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,875
+1,004 vol $3.86 each |
111,755 | |
| Filed 2017-11-11 Tx date 2017-11-10 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$164,150
+35,000 vol $4.69 each |
110,751 | |
| Filed 2017-10-20 Tx date 2017-10-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,698
+981 vol $3.77 each |
75,751 | |
| Filed 2017-10-20 Tx date 2017-10-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,206
+320 vol $3.77 each |
4,857 | |
| Filed 2017-10-20 Tx date 2017-10-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$840.71
+223 vol $3.77 each |
4,523 | |
| Filed 2017-10-19 Tx date 2017-10-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,383
+1,428 vol $3.77 each |
55,413 | |
| Filed 2017-09-25 Tx date 2017-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+8,485 vol |
13,907 | |
| Filed 2017-09-25 Tx date 2017-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+16,052 vol |
26,798 | |
| Filed 2017-09-25 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-25 Tx date 2017-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+29,151 vol |
29,151 | |
| Filed 2017-09-25 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-25 Tx date 2017-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,594 vol |
9,594 | |
| Filed 2017-09-19 Tx date 2017-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$844.20
+210 vol $4.02 each |
4,300 | |
| Filed 2017-09-19 Tx date 2017-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,242
+1,304 vol $4.02 each |
53,985 | |
| Filed 2017-09-19 Tx date 2017-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,613
+899 vol $4.02 each |
74,770 | |
| Filed 2017-09-19 Tx date 2017-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,205
+300 vol $4.02 each |
4,537 | |
| Filed 2017-09-14 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-14 Tx date 2017-08-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+8,604 vol |
8,604 | |
| Filed 2017-09-14 Tx date 2017-08-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+8,604 vol |
||
| Filed 2017-09-14 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-14 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Watters, Chris
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$185,338
+35,370 vol $5.24 each |
35,370 | |
| Filed 2017-08-20 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,013
+1,097 vol $4.57 each |
52,681 | |
| Filed 2017-08-18 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$840.88
+184 vol $4.57 each |
4,090 | |
| Filed 2017-08-18 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,206
+264 vol $4.57 each |
4,237 | |
| Filed 2017-08-18 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,614
+791 vol $4.57 each |
73,871 | |
| Filed 2017-07-22 Tx date 2017-07-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,876
+1,060 vol $4.60 each |
51,584 | |
| Filed 2017-07-20 Tx date 2017-07-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,209
+263 vol $4.60 each |
3,973 | |
| Filed 2017-07-20 Tx date 2017-07-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,610
+785 vol $4.60 each |
73,080 | |
| Filed 2017-07-20 Tx date 2017-07-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$841.80
+183 vol $4.60 each |
3,906 | |
| Filed 2017-07-04 Tx date 2017-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,830
+1,900 vol $5.70 each |
9,436,150 | |
| Filed 2017-06-29 Tx date 2017-06-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$47,311
+8,500 vol $5.57 each |
9,434,250 | |
| Filed 2017-06-27 Tx date 2017-06-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,550
+2,100 vol $5.50 each |
9,421,650 | |
| Filed 2017-06-27 Tx date 2017-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,533
+4,100 vol $5.50 each |
9,425,750 | |
| Filed 2017-06-20 Tx date 2017-06-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,870
+3,400 vol $5.55 each |
9,419,550 | |
| Filed 2017-06-20 Tx date 2017-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$36,075
+6,500 vol $5.55 each |
9,416,150 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$942.00
+200 vol $4.71 each |
3,723 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,612
+767 vol $4.71 each |
72,295 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$602.88
+128 vol $4.71 each |
3,710 | |
| Filed 2017-06-19 Tx date 2017-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,382
+1,355 vol $4.71 each |
50,524 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,640
+4,800 vol $5.55 each |
9,405,950 | |
| Filed 2017-06-15 Tx date 2017-06-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,535
+3,700 vol $5.55 each |
9,409,650 | |
| Filed 2017-06-15 Tx date 2017-06-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,750
+5,000 vol $5.55 each |
9,401,150 | |
| Filed 2017-06-13 Tx date 2017-06-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,500
+5,000 vol $5.50 each |
||
| Filed 2017-06-13 Tx date 2017-06-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,750
+5,000 vol $5.55 each |
9,396,150 | |
| Filed 2017-06-13 Tx date 2017-06-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$27,750
+5,000 vol $5.55 each |
9,391,150 | |
| Filed 2017-06-07 Tx date 2017-06-06 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,910
+1,400 vol $5.65 each |
49,169 | |
| Filed 2017-06-05 Tx date 2017-06-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$105,090
+18,600 vol $5.65 each |
47,769 | |
| Filed 2017-05-30 Tx date 2017-05-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$83,518
+15,000 vol $5.57 each |
71,528 | |
| Filed 2017-05-26 Tx date 2017-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+16,450 vol |
16,450 | |
| Filed 2017-05-26 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+19,070 vol |
26,234 | |
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+5,906 vol |
9,520 | |
| Filed 2017-05-24 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,710
+3,500 vol $5.06 each |
23,500 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,615
+833 vol $4.34 each |
22,328 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$129,743
+25,641 vol $5.06 each |
105,531 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$129,743
+25,641 vol $5.06 each |
||
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$455,399
+90,000 vol $5.06 each |
90,000 | |
| Filed 2017-05-19 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$442,056
+87,363 vol $5.06 each |
125,044 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,710
+3,500 vol $5.06 each |
23,500 | |
| Filed 2017-05-19 Tx date 2017-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$101,199
+20,000 vol $5.06 each |
20,000 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$707.42
+163 vol $4.34 each |
3,523 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$130,249
+25,741 vol $5.06 each |
59,173 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$302,906
+59,863 vol $5.06 each |
212,787 | |
| Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$136,893
+27,054 vol $5.06 each |
117,044 | |
| Filed 2017-05-18 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,710
+3,500 vol $5.06 each |
23,500 | |
| Filed 2017-05-18 Tx date 2017-05-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$129,070
+23,700 vol $5.45 each |
55,695 | |
| Filed 2017-05-17 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,098
+714 vol $4.34 each |
29,169 | |
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,330 vol |
3,439 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
31,644 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,398 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,398 vol |
2,396 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,398 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,398 vol |
3,614 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,773 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,773 vol |
4,906 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,773 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,773 vol |
7,545 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,330 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,330 vol |
1,540 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,330 vol |
||
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,092 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,092 vol |
5,849 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,092 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,092 vol |
7,870 | |
| Filed 2017-05-16 Tx date 2017-05-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Deboeck, Arthur Marie Joseph Ghislain
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
102,800 | ||
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
3,169 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,582 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,582 vol |
3,582 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,582 vol |
||
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,582 vol |
7,164 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,664 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,325 vol |
4,244 | |
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,664 vol |
7,886 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,664 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,664 vol |
4,799 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,325 vol |
||
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,325 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,325 vol |
3,429 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
16,801 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
15,003 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
20,518 | |
| Filed 2017-05-16 Tx date 2017-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,164
+10,500 vol $5.35 each |
31,995 | |
| Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
| Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-05-10 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Tessarolo, Robert Dean
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
32,900 | ||
| Filed 2017-04-20 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,226
+872 vol $3.70 each |
32,516 | |
| Filed 2017-04-20 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,614
+977 vol $3.70 each |
21,495 | |
| Filed 2017-04-20 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,614
+977 vol $3.70 each |
||
| Filed 2017-04-20 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,715
+734 vol $3.70 each |
17,535 | |
| Filed 2017-04-20 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$706.70
+191 vol $3.70 each |
3,360 | |
| Filed 2017-04-19 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,100
+838 vol $3.70 each |
28,455 | |
| Filed 2017-04-05 Tx date 2017-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
27,617 | |
| Filed 2017-04-05 Tx date 2017-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
16,801 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,325 vol |
3,429 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,664 vol |
4,799 | |
| Filed 2017-04-03 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
3,169 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,092 vol |
7,870 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,092 vol |
5,849 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,330 vol |
3,439 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,330 vol |
1,540 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,773 vol |
7,545 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,773 vol |
4,906 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,398 vol |
3,614 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,398 vol |
2,396 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
31,644 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,325 vol |
4,244 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,582 vol |
3,582 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,582 vol |
7,164 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,664 vol |
7,886 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
15,003 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
20,518 | |
| Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
| Filed 2017-03-18 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,100
+829 vol $3.74 each |
26,117 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,718
+727 vol $3.74 each |
15,301 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,616
+967 vol $3.74 each |
19,018 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$706.86
+189 vol $3.74 each |
1,669 | |
| Filed 2017-03-17 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,227
+863 vol $3.74 each |
30,144 | |
| Filed 2017-02-20 Tx date 2017-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,096
+776 vol $3.99 each |
25,288 | |
| Filed 2017-02-17 Tx date 2017-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,610
+905 vol $3.99 each |
18,051 | |
| Filed 2017-02-17 Tx date 2017-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,717
+681 vol $3.99 each |
14,574 | |
| Filed 2017-02-17 Tx date 2017-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$706.23
+177 vol $3.99 each |
1,480 | |
| Filed 2017-02-17 Tx date 2017-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,227
+809 vol $3.99 each |
29,281 | |
| Filed 2017-01-20 Tx date 2017-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,607
+893 vol $4.04 each |
17,146 | |
| Filed 2017-01-20 Tx date 2017-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,698
+668 vol $4.04 each |
13,893 | |
| Filed 2017-01-20 Tx date 2017-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$707.00
+175 vol $4.04 each |
1,303 | |
| Filed 2017-01-20 Tx date 2017-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,215
+796 vol $4.04 each |
28,472 | |
| Filed 2017-01-18 Tx date 2017-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,098
+767 vol $4.04 each |
24,512 | |
| Filed 2016-12-19 Tx date 2016-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,705
+1,074 vol $3.45 each |
16,253 | |
| Filed 2016-12-19 Tx date 2016-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$703.80
+204 vol $3.45 each |
1,128 | |
| Filed 2016-12-19 Tx date 2016-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,091
+896 vol $3.45 each |
23,745 | |
| Filed 2016-12-19 Tx date 2016-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,432
+995 vol $3.45 each |
27,676 | |
| Filed 2016-12-16 Tx date 2016-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,880
+835 vol $3.45 each |
13,225 | |
| Filed 2016-11-18 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,100
+951 vol $3.26 each |
22,849 | |
| Filed 2016-11-17 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,484
+1,069 vol $3.26 each |
15,179 | |
| Filed 2016-11-17 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,878
+883 vol $3.26 each |
12,390 | |
| Filed 2016-11-17 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$917.18
+379 vol $2.42 each |
5,222 | |
| Filed 2016-11-17 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$699.38
+289 vol $2.42 each |
2,482 | |
| Filed 2016-11-17 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$775.88
+238 vol $3.26 each |
924 | |
| Filed 2016-11-17 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,572
+1,096 vol $3.26 each |
26,681 | |
| Filed 2016-11-17 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,291
+703 vol $3.26 each |
48,080 | |
| Filed 2016-10-24 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,340
+807 vol $4.14 each |
14,110 | |
| Filed 2016-10-22 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,964
+716 vol $4.14 each |
21,898 | |
| Filed 2016-10-22 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,965
+609 vol $4.87 each |
||
| Filed 2016-10-21 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,960
+715 vol $4.14 each |
11,507 | |
| Filed 2016-10-21 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$917.28
+294 vol $3.12 each |
4,843 | |
| Filed 2016-10-21 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$698.88
+224 vol $3.12 each |
2,193 | |
| Filed 2016-10-21 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,289
+553 vol $4.14 each |
47,377 | |
| Filed 2016-10-21 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$683.10
+165 vol $4.14 each |
686 | |
| Filed 2016-10-21 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$552.24
+177 vol $3.12 each |
1,133 | |
| Filed 2016-10-21 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$894.24
+216 vol $4.14 each |
25,585 | |
| Filed 2016-09-21 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,694
+1,303 vol $4.37 each |
13,303 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,276
+521 vol $4.37 each |
521 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,945
+674 vol $4.37 each |
10,792 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$917.28
+273 vol $3.36 each |
4,549 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$917.28
+273 vol $3.36 each |
||
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$698.88
+208 vol $3.36 each |
1,969 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$698.88
+208 vol $3.36 each |
||
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,289
+524 vol $4.37 each |
46,824 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.71
+183 vol $4.37 each |
2,757 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,105
+329 vol $3.36 each |
956 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,105
+329 vol $3.36 each |
||
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,165
+1,182 vol $4.37 each |
21,182 | |
| Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,447
+789 vol $4.37 each |
25,369 | |
| Filed 2016-09-20 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+10,746 vol |
10,746 | |
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+10,746 vol |
10,746 | |
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$195,187
+37,681 vol $5.18 each |
37,681 | |
| Filed 2016-09-16 Tx date 2016-09-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Lemieux, Stephen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-09-01 Tx date 2016-08-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-200,001.40
-68,966 vol $2.90 each |
26,000 | |
| Filed 2016-09-01 Tx date 2016-08-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$200,001
+68,966 vol $2.90 each |
363,615 | |
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2016-08-18 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,800
+20,000 vol $6.19 each |
20,000 | |
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$916.16
+224 vol $4.09 each |
4,276 | |
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,290
+429 vol $5.34 each |
46,300 | |
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2016-08-18 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,800
+20,000 vol $6.19 each |
20,000 | |
| Filed 2016-08-18 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Godin, Christian
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$801.00
+150 vol $5.34 each |
2,574 | |
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,104
+270 vol $4.09 each |
627 | |
| Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,309
+1,556 vol $5.34 each |
24,580 | |
| Filed 2016-08-18 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-16 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2016-08-16 Tx date 2016-08-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$115,500
+20,000 vol $5.78 each |
20,000 | |
| Filed 2016-08-16 Tx date 2016-08-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-16 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,800
+20,000 vol $6.19 each |
20,000 | |
| Filed 2016-08-16 Tx date 2016-08-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-08-11 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,000 | ||
| Filed 2016-08-11 Tx date 2016-08-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Beaudet, Mark
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$915.40
+199 vol $4.60 each |
4,052 | |
| Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$699.20
+152 vol $4.60 each |
1,761 | |
| Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,292
+384 vol $5.97 each |
45,871 | |
| Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,599
+268 vol $5.97 each |
76,611 | |
| Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,116
+1,527 vol $5.97 each |
164,048 | |
| Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.98
+134 vol $5.97 each |
2,424 | |
| Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,104
+240 vol $4.60 each |
357 | |
| Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$8,829
+1,479 vol $5.97 each |
23,024 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-10,800
-3,750 vol $2.88 each |
79,890 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-3,000
-2,500 vol $1.20 each |
83,640 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-3,750 vol |
2,919 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$10,800
+3,750 vol $2.88 each |
6,669 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,500 vol |
2,919 | |
| Filed 2016-07-05 Tx date 2016-07-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$3,000
+2,500 vol $1.20 each |
5,419 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,457
+564 vol $6.13 each |
13,503 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,677
+763 vol $6.13 each |
10,118 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$917.62
+194 vol $4.73 each |
3,853 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$700.04
+148 vol $4.73 each |
1,609 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,292
+374 vol $6.13 each |
45,487 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,002
+653 vol $6.13 each |
76,343 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,462
+728 vol $6.13 each |
162,521 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$803.03
+131 vol $6.13 each |
2,290 | |
| Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$553.41
+117 vol $4.73 each |
117 | |
| Filed 2016-06-20 Tx date 2016-03-10 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-06-20 Tx date 2016-06-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,703
+441 vol $6.13 each |
21,545 | |
| Filed 2016-06-08 Tx date 2016-06-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-10,000 vol |
24,281 | |
| Filed 2016-06-08 Tx date 2016-06-06 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-454 vol |
2,159 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,796
+584 vol $6.50 each |
12,939 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,866
+441 vol $6.50 each |
9,355 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,640
+917 vol $5.06 each |
3,659 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,361
+862 vol $5.06 each |
1,461 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,294
+353 vol $6.50 each |
45,113 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,599
+246 vol $6.50 each |
75,690 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,458
+532 vol $6.50 each |
161,793 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.50
+123 vol $6.50 each |
2,613 | |
| Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,892
+445 vol $6.50 each |
21,104 | |
| Filed 2016-05-13 Tx date 2016-05-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Tannenbaum, Renate
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2016-05-13 Tx date 2016-05-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Tannenbaum, Renate
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-13 Tx date 2016-05-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Tannenbaum, Renate
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$151,800
+20,000 vol $7.59 each |
20,000 | |
| Filed 2016-05-13 Tx date 2016-05-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Tannenbaum, Renate
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-13 Tx date 2016-05-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Crane, Rosemary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2016-05-13 Tx date 2016-05-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Crane, Rosemary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-13 Tx date 2016-05-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Crane, Rosemary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$151,800
+20,000 vol $7.59 each |
20,000 | |
| Filed 2016-05-13 Tx date 2016-05-05 |
$CPH
Cipher Pharmaceuticals Inc. |
Crane, Rosemary
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,955
+291 vol $6.72 each |
8,914 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,205
+477 vol $6.72 each |
12,355 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$915.20
+176 vol $5.20 each |
2,742 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,024
+197 vol $5.20 each |
599 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,291
+341 vol $6.72 each |
44,760 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,599
+238 vol $6.72 each |
75,444 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,171
+472 vol $6.72 each |
161,261 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.68
+119 vol $6.72 each |
2,490 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+11,318 vol |
11,318 | |
| Filed 2016-04-20 Tx date 2016-03-10 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+11,318 vol |
11,318 | |
| Filed 2016-04-20 Tx date 2016-03-10 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$157,193
+33,805 vol $4.65 each |
33,805 | |
| Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,714
+404 vol $6.72 each |
20,659 | |
| Filed 2016-04-20 Tx date 2016-03-10 |
$CPH
Cipher Pharmaceuticals Inc. |
Bohrer, Ralph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-31 Tx date 2016-03-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,050
+1,000 vol $6.05 each |
9,386,150 | |
| Filed 2016-03-30 Tx date 2016-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,470
+1,400 vol $6.05 each |
9,385,150 | |
| Filed 2016-03-29 Tx date 2016-03-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$57,475
+9,500 vol $6.05 each |
9,383,750 | |
| Filed 2016-03-28 Tx date 2016-03-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,855
+5,100 vol $6.05 each |
9,374,250 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-692 vol |
8,623 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-181 vol |
2,919 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-175 vol |
402 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-181 vol |
210 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-185 vol |
215 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-190 vol |
998 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-692 vol |
20,255 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-692 vol |
160,789 | |
| Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-389 vol |
2,371 | |
| Filed 2016-03-24 Tx date 2016-03-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$51,425
+8,500 vol $6.05 each |
9,369,150 | |
| Filed 2016-03-21 Tx date 2016-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,550
+11,000 vol $6.05 each |
9,360,650 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$18,957
+3,550 vol $5.34 each |
10,378 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
9,315 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$14,802
+2,772 vol $5.34 each |
7,815 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-391 vol |
4,754 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+391 vol |
3,100 | |
| Filed 2016-03-20 Tx date 2016-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-529 vol |
7,463 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+529 vol |
2,566 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$915.75
+225 vol $4.07 each |
2,037 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-577 vol |
11,642 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+577 vol |
577 | |
| Filed 2016-03-20 Tx date 2015-05-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,294 vol |
31,158 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,294 vol |
44,419 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,627
+492 vol $5.34 each |
42,125 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
75,206 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,198
+599 vol $5.34 each |
73,706 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-859 vol |
11,148 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+859 vol |
34,281 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
161,481 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$12,762
+2,390 vol $5.34 each |
159,981 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-843 vol |
10,962 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$801.00
+150 vol $5.34 each |
1,917 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-391 vol |
4,769 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+391 vol |
391 | |
| Filed 2016-03-20 Tx date 2015-01-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-400 vol |
4,849 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-410 vol |
5,012 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+410 vol |
1,188 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
20,947 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,856
+2,033 vol $5.34 each |
19,447 | |
| Filed 2016-03-20 Tx date 2015-05-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
11,878 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+843 vol |
2,760 | |
| Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+400 vol |
400 | |
| Filed 2016-03-16 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
| Filed 2016-03-16 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
294,649 | |
| Filed 2016-03-14 Tx date 2016-03-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Holder: 1207407 Ontario Limited (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,025
+500 vol $6.05 each |
9,349,650 | |
| Filed 2016-03-09 Tx date 2016-03-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-82,400
-20,000 vol $4.12 each |
94,966 | |
| Filed 2016-03-09 Tx date 2016-03-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$82,400
+20,000 vol $4.12 each |
293,149 | |
| Filed 2016-03-04 Tx date 2016-03-03 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-82,400
-20,000 vol $4.12 each |
26,000 | |
| Filed 2016-03-04 Tx date 2016-03-03 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$82,400
+20,000 vol $4.12 each |
73,107 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,950
+5,000 vol $6.79 each |
20,750 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,950
+5,000 vol $6.79 each |
28,500 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,973 vol |
5,145 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+3,973 vol |
5,145 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$73,943
+10,890 vol $6.79 each |
86,140 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+6,406 vol |
7,992 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+6,406 vol |
7,992 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$86,314
+17,508 vol $4.93 each |
32,674 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+10,489 vol |
12,219 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+10,489 vol |
12,219 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$141,323
+28,666 vol $4.93 each |
62,666 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+26,569 vol |
33,452 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+26,569 vol |
33,452 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$494,502
+72,828 vol $6.79 each |
382,828 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,950
+5,000 vol $6.79 each |
46,000 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+9,430 vol |
12,007 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,430 vol |
12,007 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$175,501
+25,847 vol $6.79 each |
298,347 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,950
+5,000 vol $6.79 each |
22,500 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+9,275 vol |
11,805 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,275 vol |
11,805 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$172,628
+25,424 vol $6.79 each |
152,924 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+3,988 vol |
5,160 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+3,988 vol |
5,160 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$74,228
+10,932 vol $6.79 each |
33,432 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+4,048 vol |
5,249 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+4,048 vol |
5,249 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,348
+11,097 vol $6.79 each |
35,097 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+4,192 vol |
5,422 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+4,192 vol |
5,422 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$78,017
+11,490 vol $6.79 each |
89,990 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
| Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$33,950
+5,000 vol $6.79 each |
46,000 | |
| Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,002
+687 vol $4.37 each |
6,828 | |
| Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,001
+458 vol $4.37 each |
5,043 | |
| Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$915.20
+286 vol $3.20 each |
1,812 | |
| Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,957
+448 vol $4.37 each |
41,633 | |
| Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,599
+366 vol $4.37 each |
53,107 | |
| Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,600
+595 vol $4.37 each |
157,591 | |
| Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.71
+183 vol $4.37 each |
1,767 | |
| Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,001
+458 vol $4.37 each |
17,414 | |
| Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,048
+1,186 vol $5.10 each |
6,141 | |
| Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,416
+670 vol $5.10 each |
4,585 | |
| Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$918.39
+253 vol $3.63 each |
1,526 | |
| Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$902.70
+177 vol $5.10 each |
41,185 | |
| Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$800.70
+157 vol $5.10 each |
52,741 | |
| Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$397.80
+78 vol $5.10 each |
156,996 | |
| Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,866
+366 vol $5.10 each |
16,956 | |
| Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$397.80
+78 vol $5.10 each |
1,584 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,788
+601 vol $4.64 each |
4,955 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,605
+346 vol $4.64 each |
3,915 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$162.40
+35 vol $4.64 each |
2,709 | |
| Filed 2015-12-17 Tx date 2015-12-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-3,200 vol |
2,674 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,069
+328 vol $3.26 each |
1,273 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,146
+1,272 vol $3.26 each |
||
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,146
+1,272 vol $3.26 each |
5,550 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,814
+391 vol $4.64 each |
41,008 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,600
+345 vol $4.64 each |
52,584 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,398
+517 vol $4.64 each |
156,918 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$812.00
+175 vol $4.64 each |
1,506 | |
| Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,197
+258 vol $4.64 each |
16,590 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,983
+775 vol $5.14 each |
4,354 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,245
+826 vol $5.14 each |
3,569 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,307
+449 vol $5.14 each |
5,874 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$778.14
+198 vol $3.93 each |
945 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,000
+1,018 vol $3.93 each |
4,278 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,713
+528 vol $5.14 each |
40,617 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,400
+467 vol $5.14 each |
52,239 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,343
+845 vol $5.14 each |
156,401 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,197
+233 vol $5.14 each |
1,331 | |
| Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,140
+611 vol $5.14 each |
16,332 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,788
+801 vol $4.73 each |
3,579 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,395
+295 vol $4.73 each |
2,743 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Weiler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,298
+486 vol $4.73 each |
5,425 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$917.87
+263 vol $3.49 each |
747 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,999
+1,146 vol $3.49 each |
3,260 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,700
+571 vol $4.73 each |
40,089 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,388
+505 vol $4.73 each |
51,772 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$198.66
+42 vol $4.73 each |
33,422 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,890
+611 vol $4.73 each |
155,556 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,196
+253 vol $4.73 each |
1,098 | |
| Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,890
+611 vol $4.73 each |
15,721 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,601
+473 vol $5.50 each |
2,778 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wieler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,540
+280 vol $5.50 each |
4,939 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,001
+182 vol $5.50 each |
2,448 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$915.60
+218 vol $4.20 each |
484 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,998
+952 vol $4.20 each |
2,114 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$11,808
+2,147 vol $5.50 each |
39,518 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,600
+291 vol $5.50 each |
51,267 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$19,998
+3,636 vol $5.50 each |
33,380 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$797.50
+145 vol $5.50 each |
845 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,002
+364 vol $5.50 each |
15,110 | |
| Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,002
+364 vol $5.50 each |
154,945 | |
| Filed 2015-09-15 Tx date 2015-09-10 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,000
-20,000 vol $0.55 each |
17,500 | |
| Filed 2015-09-15 Tx date 2015-09-10 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,000
+20,000 vol $0.55 each |
154,581 | |
| Filed 2015-09-09 Tx date 2015-09-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Holder: Wiseman MCS Inc. (Control or Direction)
|
Common Shares
97 - Other
|
+25,000 vol |
25,000 | |
| Filed 2015-09-09 Tx date 2005-08-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Holder: Wiseman MCS Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-09 Tx date 2015-09-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Holder: The Stephen and Elaine Wiseman Family Trust (Control or Direction)
|
Common Shares
97 - Other
|
-25,000 vol |
0 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,602
+304 vol $8.56 each |
2,305 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wieler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,540
+180 vol $8.56 each |
4,659 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,001
+117 vol $8.56 each |
2,266 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$916.37
+133 vol $6.89 each |
266 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,003
+581 vol $6.89 each |
1,162 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,806
+211 vol $8.56 each |
37,371 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,600
+187 vol $8.56 each |
50,976 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,003
+234 vol $8.56 each |
134,581 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$796.08
+93 vol $8.56 each |
700 | |
| Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,003
+234 vol $8.56 each |
14,746 | |
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,582
+408 vol $8.78 each |
2,001 | |
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wieler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,536
+175 vol $8.78 each |
4,479 | |
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,441
+392 vol $8.78 each |
2,149 | |
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$916.37
+133 vol $6.89 each |
133 | |
| Filed 2015-07-20 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,003
+581 vol $6.89 each |
581 | |
| Filed 2015-07-20 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,808
+206 vol $8.78 each |
37,160 | |
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$798.98
+91 vol $8.78 each |
607 | |
| Filed 2015-07-20 Tx date 2015-07-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,748
+313 vol $8.78 each |
14,512 | |
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,597
+182 vol $8.78 each |
50,789 | |
| Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,415
+389 vol $8.78 each |
134,347 | |
| Filed 2015-07-03 Tx date 2015-06-29 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$71,448
+8,203 vol $8.71 each |
36,954 | |
| Filed 2015-07-03 Tx date 2015-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-85,040
-8,000 vol $10.63 each |
14,199 | |
| Filed 2015-07-02 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2015-07-02 Tx date 2004-02-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Mull, John
3 - 10% Security Holder of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2005-08-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Wieler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,172 vol |
1,172 | |
| Filed 2015-06-30 Tx date 2015-01-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Wieler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Wieler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+1,172 vol |
1,172 | |
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2015-06-30 Tx date 2014-03-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,586 vol |
1,586 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+1,586 vol |
1,586 | |
| Filed 2015-06-30 Tx date 2015-01-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Wieler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$131,489
+15,166 vol $8.67 each |
15,166 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Spina, Mark
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,730 vol |
1,730 | |
| Filed 2015-06-30 Tx date 2015-05-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+1,730 vol |
1,730 | |
| Filed 2015-06-30 Tx date 2015-05-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,768 vol |
2,768 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+2,768 vol |
2,768 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$229,512
+26,472 vol $8.67 each |
26,472 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Pecora, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$73,441
+6,883 vol $10.67 each |
6,883 | |
| Filed 2015-06-30 Tx date 2014-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+6,883 vol |
6,883 | |
| Filed 2015-06-30 Tx date 2014-06-30 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2015-06-30 Tx date 2004-02-23 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,577 vol |
2,577 | |
| Filed 2015-06-30 Tx date 2007-03-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+2,577 vol |
2,577 | |
| Filed 2015-06-30 Tx date 2007-03-09 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2015-06-30 Tx date 2009-11-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,530 vol |
2,530 | |
| Filed 2015-06-30 Tx date 2013-03-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+2,530 vol |
2,530 | |
| Filed 2015-06-30 Tx date 2013-03-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,172 vol |
1,172 | |
| Filed 2015-06-30 Tx date 2015-01-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+1,172 vol |
1,172 | |
| Filed 2015-06-30 Tx date 2015-01-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Bulger, Lynne Cheryl
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,201 vol |
1,201 | |
| Filed 2015-06-30 Tx date 2015-05-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+1,201 vol |
1,201 | |
| Filed 2015-06-30 Tx date 2015-05-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,230 vol |
1,230 | |
| Filed 2015-06-30 Tx date 2015-01-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+1,230 vol |
1,230 | |
| Filed 2015-06-30 Tx date 2015-01-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Angaritis, Linda Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Alba, Jonathan David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,847 vol |
1,847 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Alba, Jonathan David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Alba, Jonathan David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+1,847 vol |
1,847 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Alba, Jonathan David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Alba, Jonathan David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$153,146
+17,664 vol $8.67 each |
17,664 | |
| Filed 2015-06-30 Tx date 2015-04-13 |
$CPH
Cipher Pharmaceuticals Inc. |
Alba, Jonathan David
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
| Filed 2015-06-30 Tx date 2007-12-06 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-06-30 Tx date 2015-06-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-106,700
-10,000 vol $10.67 each |
22,199 | |
| Filed 2015-06-24 Tx date 2015-06-19 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-127,848
-12,000 vol $10.65 each |
32,199 | |
| Filed 2015-06-02 Tx date 2015-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,500 vol |
37,500 | |
| Filed 2015-06-02 Tx date 2015-02-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,500 vol |
||
| Filed 2015-05-29 Tx date 2015-05-27 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,302
+1,800 vol $12.39 each |
28,751 | |
| Filed 2015-05-29 Tx date 2015-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$101,598
+8,200 vol $12.39 each |
26,951 | |
| Filed 2015-05-28 Tx date 2015-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$342,040
+34,000 vol $10.06 each |
34,000 | |
| Filed 2015-05-28 Tx date 2015-05-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Rosenberger, Brian
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Wiseman, Stephen R.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,598
+346 vol $10.40 each |
1,593 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Wieler, Peter John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,308
+222 vol $10.40 each |
4,304 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Wellner, Thomas Gordon
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,196
+115 vol $10.40 each |
1,757 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
O'Brien, Shawn Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,714
+261 vol $10.40 each |
18,751 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
McDole, Gerald P.
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,402
+231 vol $10.40 each |
50,607 | |
| Filed 2015-05-27 Tx date 2015-05-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-18,000
-15,000 vol $1.20 each |
272,500 | |
| Filed 2015-05-27 Tx date 2015-05-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-23,200
-20,000 vol $1.16 each |
287,500 | |
| Filed 2015-05-27 Tx date 2015-05-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-16,000
-10,000 vol $1.60 each |
307,500 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,196
+115 vol $10.40 each |
29,744 | |
| Filed 2015-05-27 Tx date 2015-05-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-45,000 vol |
29,629 | |
| Filed 2015-05-27 Tx date 2015-05-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$18,000
+15,000 vol $1.20 each |
74,629 | |
| Filed 2015-05-27 Tx date 2015-05-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$23,200
+20,000 vol $1.16 each |
59,629 | |
| Filed 2015-05-27 Tx date 2015-05-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,000
+10,000 vol $1.60 each |
39,629 | |
| Filed 2015-05-27 Tx date 2015-05-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Evans, Norman Charles
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-5,000 vol |
29,629 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Claypool, William
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,704
+260 vol $10.40 each |
133,958 | |
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,196
+115 vol $10.40 each |
516 | |
| Filed 2015-05-27 Tx date 2015-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$288,720
+24,000 vol $12.03 each |
24,000 | |
| Filed 2015-05-27 Tx date 2015-05-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Blythe, Louis
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Aigner, Stefan
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$2,704
+260 vol $10.40 each |
44,199 |